Literature DB >> 17097232

Mammalian cytochromes P450--importance of tissue specificity.

Matej Seliskar1, Damjana Rozman.   

Abstract

Mammals express multiple cytochromes P450 simultaneously in a variety of tissues, including the liver, kidney, lung, adrenal, gonads, brain, and most others. For cytochromes P450 that are expressed in many tissues or cell types, the tissue/cell type-specific expression might be associated with their special physiological roles. Several cytochrome P450 enzymes are found not only in different cell types and tissues, but also in different subcellular compartments. Generally, all mammalian cytochrome P450 enzymes are membrane bound. The two major groups are represented by microsomal cytochromes P450 that reside in the endoplasmic reticulum, and mitochondrial cytochromes P450, that reside in the inner mitochondrial membrane. However, the outer nuclear membrane, different Golgi compartments, peroxisomes and the plasma membrane are also sites where cytochromes P450 were observed. For example, CYP51 is an ER enzyme in majority of tissues but in male germ cells it trafficks through the Golgi to acrosome, where it is stabilized for several weeks. Surprisingly, in brains of heme synthesis deficient mice, a soluble form of CYP1A1 was detected whose activity has been restored by the addition of heme. In the majority of cases each cytochrome P450 enzyme resides in a single subcellular compartment in a certain cell, however, examples of simultaneous localization in different subcellular compartments have also been described, such as endoplasmic reticulum, Golgi and plasma membrane for CYP2E1. This review will focus on the physiological importance of mammalian cytochrome P450 expression and localization in different tissues or cell types and subcellular compartments.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17097232     DOI: 10.1016/j.bbagen.2006.09.016

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  34 in total

1.  Molecular characterization of the Camelus dromedarius putative cytochrome P450s genes.

Authors:  Mohammad Saud Alanazi; Hesham Mahmoud Saeed; Farid Shokry Ataya; Mohammad Dawoud Bazzi
Journal:  Protein J       Date:  2010-07       Impact factor: 2.371

2.  Isolation and characterization of the CYP2D6 gene in Felidae with comparison to other mammals.

Authors:  Tamara Schenekar; Kathrin A Winkler; Jennifer L Troyer; Steven Weiss
Journal:  J Mol Evol       Date:  2010-12-28       Impact factor: 2.395

3.  Cytosolic phospholipase A2α is critical for angiotensin II-induced hypertension and associated cardiovascular pathophysiology.

Authors:  Nayaab S Khan; Chi Young Song; Brett L Jennings; Anne M Estes; Xiao R Fang; Joseph V Bonventre; Kafait U Malik
Journal:  Hypertension       Date:  2015-02-09       Impact factor: 10.190

4.  Biomedical Technologies for in vitro Screening and Controlled Delivery of Neuroactive Compounds.

Authors:  John P Frampton; Michael L Shuler; William Shain; Matthew R Hynd
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2008

5.  Cyclophosphamide enhances the immunosuppressive action of its own active metabolites.

Authors:  L Y Telegin; V M Pisarev; L A Pevnitsky
Journal:  Dokl Biol Sci       Date:  2008 Nov-Dec

6.  Cytochromes P450, induction and cholesterol--what are the connections?

Authors:  Olavi Pelkonen; Jukka Hakkola
Journal:  Eur J Clin Pharmacol       Date:  2008-07-17       Impact factor: 2.953

7.  Brain drug-metabolizing cytochrome P450 enzymes are active in vivo, demonstrated by mechanism-based enzyme inhibition.

Authors:  Sharon Miksys; Rachel F Tyndale
Journal:  Neuropsychopharmacology       Date:  2008-07-30       Impact factor: 7.853

Review 8.  Role of Alcohol Oxidative Metabolism in Its Cardiovascular and Autonomic Effects.

Authors:  Mahmoud M El-Mas; Abdel A Abdel-Rahman
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

9.  Novel functionalized 5-(phenoxymethyl)-1,3-dioxane analogs exhibiting cytochrome P450 inhibition: a patent evaluation WO2015048311 (A1).

Authors:  Richard L Schroeder; Phan Tram; Jiawang Liu; Maryam Foroozesh; Jayalakshmi Sridhar
Journal:  Expert Opin Ther Pat       Date:  2015-10-29       Impact factor: 6.674

10.  Selective induction of tumor cell apoptosis by a novel P450-mediated reactive oxygen species (ROS) inducer methyl 3-(4-nitrophenyl) propiolate.

Authors:  Xiaoxiao Sun; Midan Ai; Ying Wang; Shensi Shen; Yuan Gu; Yi Jin; Zuyu Zhou; Yaqiu Long; Qiang Yu
Journal:  J Biol Chem       Date:  2013-02-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.